MedTrace Logo

Evaluation of the Impact of a Connected Application on the Follow-up of Patients Treated for Glial Lesions Operated

NCT05067049 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2021-10-04

No results posted yet for this study

Summary

This study is to evaluate the efficacy of a mobile app for monitoring the quality of life of patients but also on detection delay of side effects and/or complications linked to the therapeutic management. This allow to adapt their care more quickly, through a prospective randomized study. The impact of this connected monitoring of patients' anxiety will also be evaluated in this study as well as the time taken by the medical team to manage alerts generated by this application.

Conditions

  • Quality of Life
  • Phone Use, Cell
  • Glial Scar

Interventions

DEVICE

Connected application arm

patients have to respond different questionnaires about their quality of life on the mobile app. And follow-up visits with the physicians as usual

DEVICE

Unconnected arm

Follow-up visits with the pysicians as usual

Sponsors & Collaborators

  • Clairval Hospital

    collaborator UNKNOWN

  • Ramsay Générale de Santé

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05067049 on ClinicalTrials.gov